COMMUNIQUÉS West-GlobeNewswire

Jounce Therapeutics to Present at Upcoming Investor Conferences in September
28/08/2019
CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright
28/08/2019
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will present at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored [...]
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Immunomedics to Participate in Upcoming Healthcare Conferences
28/08/2019
MORRIS PLAINS, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
CareDx Acquires XynManagement
28/08/2019
Acquisition solidifies transplant leadership with transplant center quality management and patient waitlist management tools BRISBANE, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading [...]
United Health Products Announces Completion of Human Trial Study
28/08/2019
HENDERSON, Nev., Aug. 28, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through [...]
Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019
28/08/2019
CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury
28/08/2019
PRINCETON, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics., a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous System (CNS) [...]
Media Statement Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment Further Promising Results
28/08/2019
SYDNEY, Australia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Noxopharm (ASX: NOX) (‘ Noxopharm’ or the ‘ Company’ ) today announced the interim three month results from the second part of the DARRT-1 study on its proprietary [...]
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28/08/2019
New Scientific Information Further Highlights Clinical Profiles of BELBUCA® and Symproic® RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing [...]
SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019
28/08/2019
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGA [...]
Matinas BioPharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference
28/08/2019
BEDMINSTER, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, today announced that Jerome D. Jabbour, Chief Executive Officer, will [...]
VIVUS to Present at Upcoming Conferences
28/08/2019
CAMPBELL, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced that John Amos, Chief Executive Officer at VIVUS, will present at the [...]
The Ensign Group, Inc. Announces Record and Distribution Dates for Pennant Spin-Off
28/08/2019
SAN JUAN CAPISTRANO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]
Helius Medical Technologies, Inc. Provides a Business Update on Clinical Experience to Date in Canada
28/08/2019
NEWTOWN, Pa., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today is providing an update [...]
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 21st Annual Global Investment Conference
28/08/2019
WEST CHESTER, Pa., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that [...]
Nabriva Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
28/08/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti- [...]
Applied Therapeutics to Present at Baird’s 2019 Global Healthcare Conference
28/08/2019
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, announced [...]
ContraFect Announces Presentation of New Data from its Amurin Peptide Program at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
28/08/2019
YONKERS, N.Y., Aug. 28, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and [...]

Pages